510 related articles for article (PubMed ID: 26719268)
1. Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites.
Wang A; Welch R; Zhao B; Ta T; Keleş S; Johannsen E
J Virol; 2015 Dec; 90(6):2906-19. PubMed ID: 26719268
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes.
Schmidt SC; Jiang S; Zhou H; Willox B; Holthaus AM; Kharchenko PV; Johannsen EC; Kieff E; Zhao B
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):554-9. PubMed ID: 25540416
[TBL] [Abstract][Full Text] [Related]
3. The EBNA3 family of Epstein-Barr virus nuclear proteins associates with the USP46/USP12 deubiquitination complexes to regulate lymphoblastoid cell line growth.
Ohashi M; Holthaus AM; Calderwood MA; Lai CY; Krastins B; Sarracino D; Johannsen E
PLoS Pathog; 2015 Apr; 11(4):e1004822. PubMed ID: 25855980
[TBL] [Abstract][Full Text] [Related]
4. The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(kappa).
Robertson ES; Lin J; Kieff E
J Virol; 1996 May; 70(5):3068-74. PubMed ID: 8627785
[TBL] [Abstract][Full Text] [Related]
5. Core binding factor (CBF) is required for Epstein-Barr virus EBNA3 proteins to regulate target gene expression.
Paschos K; Bazot Q; Ho G; Parker GA; Lees J; Barton G; Allday MJ
Nucleic Acids Res; 2017 Mar; 45(5):2368-2383. PubMed ID: 27903901
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the
Bazot Q; Paschos K; Allday MJ
J Virol; 2018 Apr; 92(7):. PubMed ID: 29367247
[TBL] [Abstract][Full Text] [Related]
7. EBV epigenetically suppresses the B cell-to-plasma cell differentiation pathway while establishing long-term latency.
Styles CT; Bazot Q; Parker GA; White RE; Paschos K; Allday MJ
PLoS Biol; 2017 Aug; 15(8):e2001992. PubMed ID: 28771465
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr Virus Nuclear Antigen 3C Inhibits Expression of
Gillman ACT; Parker G; Allday MJ; Bazot Q
J Virol; 2018 Nov; 92(21):. PubMed ID: 30135119
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional repression by the Epstein-Barr virus EBNA3A protein tethered to DNA does not require RBP-Jkappa.
Bourillot PY; Waltzer L; Sergeant A; Manet E
J Gen Virol; 1998 Feb; 79 ( Pt 2)():363-70. PubMed ID: 9472621
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-J kappa-EBNA2-activated transcription by inhibiting the binding of RBP-J kappa to DNA.
Waltzer L; Perricaudet M; Sergeant A; Manet E
J Virol; 1996 Sep; 70(9):5909-15. PubMed ID: 8709211
[TBL] [Abstract][Full Text] [Related]
11. The EBNA3 Family: Two Oncoproteins and a Tumour Suppressor that Are Central to the Biology of EBV in B Cells.
Allday MJ; Bazot Q; White RE
Curr Top Microbiol Immunol; 2015; 391():61-117. PubMed ID: 26428372
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus nuclear protein 3C binds to the N-terminal (NTD) and beta trefoil domains (BTD) of RBP/CSL; only the NTD interaction is essential for lymphoblastoid cell growth.
Calderwood MA; Lee S; Holthaus AM; Blacklow SC; Kieff E; Johannsen E
Virology; 2011 May; 414(1):19-25. PubMed ID: 21440926
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth.
Zhao B; Zou J; Wang H; Johannsen E; Peng CW; Quackenbush J; Mar JC; Morton CC; Freedman ML; Blacklow SC; Aster JC; Bernstein BE; Kieff E
Proc Natl Acad Sci U S A; 2011 Sep; 108(36):14902-7. PubMed ID: 21746931
[TBL] [Abstract][Full Text] [Related]
14. Extensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification.
White RE; Groves IJ; Turro E; Yee J; Kremmer E; Allday MJ
PLoS One; 2010 Nov; 5(11):e13979. PubMed ID: 21085583
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus nuclear antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2A.
Jiang S; Willox B; Zhou H; Holthaus AM; Wang A; Shi TT; Maruo S; Kharchenko PV; Johannsen EC; Kieff E; Zhao B
Proc Natl Acad Sci U S A; 2014 Jan; 111(1):421-6. PubMed ID: 24344258
[TBL] [Abstract][Full Text] [Related]
16. EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding.
Portal D; Zhao B; Calderwood MA; Sommermann T; Johannsen E; Kieff E
Proc Natl Acad Sci U S A; 2011 May; 108(19):7808-13. PubMed ID: 21518914
[TBL] [Abstract][Full Text] [Related]
17. Regulation of B cell receptor signalling by Epstein-Barr virus nuclear antigens.
Khasnis S; Veenstra H; McClellan MJ; Ojeniyi O; Wood CD; West MJ
Biochem J; 2022 Dec; 479(23):2395-2417. PubMed ID: 36383217
[TBL] [Abstract][Full Text] [Related]
18. Requirement for PRC1 subunit BMI1 in host gene activation by Epstein-Barr virus protein EBNA3C.
Paschos K; Bazot Q; Lees J; Farrell PJ; Allday MJ
Nucleic Acids Res; 2019 Apr; 47(6):2807-2821. PubMed ID: 30649516
[TBL] [Abstract][Full Text] [Related]
19. First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus.
Pich D; Mrozek-Gorska P; Bouvet M; Sugimoto A; Akidil E; Grundhoff A; Hamperl S; Ling PD; Hammerschmidt W
mBio; 2019 Sep; 10(5):. PubMed ID: 31530670
[TBL] [Abstract][Full Text] [Related]
20. Enhancer Control of MicroRNA miR-155 Expression in Epstein-Barr Virus-Infected B Cells.
Wood CD; Carvell T; Gunnell A; Ojeniyi OO; Osborne C; West MJ
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]